Literature DB >> 11001935

Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase.

J P Mounsey1, D J Mistry, C W Ai, S Reddy, J R Moorman.   

Abstract

Myotonic dystrophy, a progressive autosomal dominant disorder, is associated with an expansion of a CTG repeat tract located in the 3'-untranslated region of a serine/threonine protein kinase, DMPK. DMPK modulates skeletal muscle Na channels in vitro, and thus we hypothesized that mice deficient in DMPK would have altered muscle Na channel gating. We measured macroscopic and single channel Na currents from cell-attached patches of skeletal myocytes from mice heterozygous (DMPK(+/-)) and homozygous (DMPK(-/-)) for DMPK loss. In DMPK(-/-) myocytes, Na current amplitude was reduced because of reduced channel number. Single channel recordings revealed Na channel reopenings, similar to the gating abnormality of human myotonic muscular dystrophy (DM), which resulted in a plateau of Na current. The gating abnormality deteriorated with increasing age. In DMPK(+/-) muscle there was reduced Na current amplitude and increased Na channel reopenings identical to those in DMPK(-/-) muscle. Thus, these mouse models of complete and partial DMPK deficiency reproduce the Na channel abnormality of the human disease, providing direct evidence that DMPK deficiency underlies the Na channel abnormality in DM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001935     DOI: 10.1093/oxfordjournals.hmg.a018923

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

Review 1.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

Review 2.  Mouse models of triplet repeat diseases.

Authors:  Gillian P Bates; Roman Gonitel
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

3.  Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.

Authors:  John D Lueck; Ami Mankodi; Maurice S Swanson; Charles A Thornton; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2006-12-11       Impact factor: 4.086

Review 4.  Regulation of sodium channel activity by phosphorylation.

Authors:  Todd Scheuer
Journal:  Semin Cell Dev Biol       Date:  2010-10-13       Impact factor: 7.727

5.  Sodium Channel Inhibitors Reduce DMPK mRNA and Protein.

Authors:  Luke Witherspoon; Sean O'Reilly; Jeremiah Hadwen; Nafisa Tasnim; Alex MacKenzie; Faraz Farooq
Journal:  Clin Transl Sci       Date:  2015-05-22       Impact factor: 4.689

Review 6.  Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases.

Authors:  Lise Barbé; Steve Finkbeiner
Journal:  Front Aging Neurosci       Date:  2022-05-03       Impact factor: 5.702

Review 7.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

8.  Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization.

Authors:  Derick G Wansink; René E M A van Herpen; Marga M Coerwinkel-Driessen; Patricia J T A Groenen; Brian A Hemmings; Bé Wieringa
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  In vivo assessment of muscle membrane properties in myotonic dystrophy.

Authors:  S Veronica Tan; Werner J Z'graggen; Delphine Boërio; Christopher Turner; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2016-05-24       Impact factor: 3.217

10.  Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood.

Authors:  Lauren Buckley; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenomics       Date:  2016-01-12       Impact factor: 4.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.